Biomedical Engineering Reference
In-Depth Information
[114] Maeda, H., Bharate, G.Y., and Daruwalla, J., “Polymeric drugs for efficient tumor-targeted
drug delivery based on EPR-effect,”
Eur J Pharm Biopharm
, Vol.71, No.3, 2009, pp. 409-
19.
[115] Lukyanov, A.N., and Torchilin, V.P., “Micelles from lipid derivatives of water-soluble
polymers as delivery systems for poorly soluble drugs,”
Adv Drug Deliv Rev
, Vol. 56, No.
9, 2004, pp. 1273-89.
[116] Lukyanov, A.N., et al., “Polyethylene glycol-diacyllipid micelles demonstrate increased
accumulation in subcutaneous tumors in mice,”
Pharm Res
, Vol. 19, No. 10, 2002, pp.
1424-9.
[117] Torchilin, V.P., et al., “TAT peptide on the surface of liposomes affords their efficient
intracellular delivery even at low temperature and in the presence of metabolic inhibitors,”
Proc Natl Acad Sci U S A
, Vol. 98, No. 15, 2001, pp. 8786-91.
[118] Torchilin, V.P., et al., “Cell transfection in vitro and in vivo with nontoxic TAT peptide-
liposome-DNA complexes,”
Proc Natl Acad Sci U S A
, Vol. 100, No. 4, 2003, pp. 1972-7.
[119] Tseng, Y.L., Liu, J.J., and Hong, R.L., “Translocation of liposomes into cancer cells by
cell-penetrating peptides penetratin and tat: a kinetic and efficacy study,”
Mol Pharmacol
,
Vol. 62, No. 4, 2002, pp. 864-72.
[120] Fretz, M.M., et al., “OVCAR-3 cells internalize TAT-peptide modified liposomes by
endocytosis,”
Biochim Biophys Acta
, Vol. 1665, No. 1-2, 2004, pp. 48-56.
[121] Marty, C., et al., “Enhanced heparan sulfate proteoglycan-mediated uptake of cell-
penetrating peptide-modified liposomes,”
Cell Mol Life Sci
, Vol. 61, No. 14, 2004, pp.
1785-94.
[122] Sawant, R.R., et al., “The architecture of ligand attachment to nanocarriers controls their
specific interaction with target cells,”
J Drug Target
, Vol. 16, No. 7, 2008, pp. 596-600.
[123] Ignatovich, I.A., et al., “Complexes of plasmid DNA with basic domain 47-57 of the HIV-1
Tat protein are transferred to mammalian cells by endocytosis-mediated pathways,”
J Biol
Chem
, Vol. 278, No. 43, 2003, pp. 42625-36.
[124] Rudolph, C., et al., “Application of novel solid lipid nanoparticle (SLN)-gene vector
formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo,”
Pharm Res
, Vol.
21, No. 9, 2004, pp. 1662-9.
[125] Huang, Z., et al., “Thiocholesterol-based lipids for ordered assembly of bioresponsive gene
carriers,”
Mol Ther
, Vol. 11, No. 3, 2005, pp. 409-17.
[126] Gupta, B., Levchenko, T.S., and Torchilin, V.P., “TAT peptide-modified liposomes provide
enhanced gene delivery to intracranial human brain tumor xenografts in nude mice,”
Oncol
Res
, Vol. 16, No. 8, 2007, pp. 351-9.
[127] Pappalardo, J.S., et al., “Improved transfection of spleen-derived antigen-presenting cells in
culture using TATp-liposomes,”
J Control Release
, Vol. 134, No. 1, 2009, pp. 41-6.
[128] Ko, Y.T., et al., “Gene delivery into ischemic myocardium by double-targeted lipoplexes
with anti-myosin antibody and TAT peptide,”
Gene Ther
, Vol. 16, No. 1, 2009, pp. 52-9.
[129] Kogure, K., et al., “Development of a non-viral multifunctional envelope-type nano device
by a novel lipid film hydration method,”
J Control Release
, Vol. 98, No. 2, 2004, pp. 317-
23.
[130] Kleemann, E., et al., “Nano-carriers for DNA delivery to the lung based upon a TAT-
derived peptide covalently coupled to PEG-PEI,”
J Control Release
, Vol. 109, No. 1-3,
2005, pp. 299-316.
[131] Nguyen, J., et al., “Effects of cell-penetrating peptides and pegylation on transfection
efficiency of polyethylenimine in mouse lungs,”
J Gene Med
, Vol. 10, No. 11, 2008, pp.
1236-46.
[132] Juliano, R.L., “Intracellular delivery of oligonucleotide conjugates and dendrimer
complexes,”
Ann N Y Acad Sci
, Vol. 1082, No. 2006, pp. 18-26.
Search WWH ::
Custom Search